The industry's challenge is to develop and proactively propose forward-looking credible alternatives that address the tensions within the Government, benefit the system, and progress its long-term objectives. These alternatives can delay and potentially prevent the more undesirable options.
Developing and proactively proposing credible alternatives will delay or prevent worst outcomes
March 20, 2024 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Australians with chronic disease call for stronger investment in PBS
October 29, 2025 - - Latest News -
Australia launches first clinical and commercial-scale viral vector manufacturing facility
October 28, 2025 - - Latest News -
Myrio Therapeutics partners with leading US research institutions to advance T cell immunotherapies for solid tumours
October 28, 2025 - - Australian Biotech -
MTPConnect signs cooperation agreement with Saudi Ministry of Health to boost life sciences collaboration
October 28, 2025 - - Australian Biotech -
ObvioHealth partners with Vaxxas to advance needle-free vaccination through digital clinical trials
October 28, 2025 - - Australian Biotech -
AbbVie appoints David Manifold to lead Immunology ANZ and New Zealand operations
October 28, 2025 - - Latest News -
Australians want better access to medical technology, and a clearer pathway to get there
October 28, 2025 -
